Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
Authors:
- Anders PaetauAPAnders Paetau
- Tuomo PolvikoskiTPTuomo Polvikoski
- Maarit TanskanenMTMaarit Tanskanen
- Raimo SulkavaRSRaimo Sulkava
- Lilja JanssonLJLilja Jansson
- Liisa MyllykangasLMLiisa Myllykangas
- Pentti J. TienariPTPentti J. Tienari
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 34 (5) , 1518.e1-1518.e3
Abstract
No abstract availableKeywords
Funding Information
- Finnish Academy
- University of Helsinki
- Folkhälsan Research Foundation
- Helsinki University Central Hospital
This publication has 9 references indexed in Scilit:
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive declineNature, 2012
- The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOENeurobiology of Aging, 2012
- Prevalence and severity of cerebral amyloid angiopathy: a population‐based study on very elderly Finns (Vantaa 85+)Neuropathology and Applied Neurobiology, 2011
- APOE and AβPP Gene Variation in Cortical and Cerebrovascular Amyloid-β Pathology and Alzheimer's Disease: A Population-Based AnalysisJournal of Alzheimer’s Disease, 2011
- Neuropathologic Findings of Dementia with Lewy Bodies (DLB) in a Population-based Vantaa 85+ StudyJournal of Alzheimer’s Disease, 2009
- Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotypeNeuropathology and Applied Neurobiology, 2005
- Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s diseaseNeurobiology of Aging, 2004
- Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid ProteinNew England Journal of Medicine, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991